Is CFD Overkill for Your Scale-Up? Why It Belongs in Every Biotech Scientist’s Toolkit – Part 1
Can computational fluid dynamics (CFD) join the ranks of everyday tools in bioprocess engineering—right alongside spreadsheets and pH meters?
The Fool’s Game That Became Standard Practice: Perfusion, the ATF, and What Changed – Part 2
How do you know when your biotech startup is ready to sell—before the product is “perfect”?
The Fool’s Game That Became Standard Practice: Perfusion, the ATF, and What Changed – Part 1
Most bioprocess innovation is dismissed as a “fool’s game”—until the skeptics are proven wrong.
Batch-to-Batch Variability Is a Design Failure, Not the Norm – Part 2
Biotech startups face a labyrinth of decisions when it comes to manufacturing strategy.
Batch-to-Batch Variability Is a Design Failure, Not the Norm – Part 1
What if batch-to-batch variability was no longer just “part of the job” in tissue engineering and in vitro biology?
Why the Cell Line Is the CMC Decision You Don’t Get to Undo – Part 2
Is your next blockbuster biologic doomed before your team even steps into a lab?
Why the Cell Line Is the CMC Decision You Don’t Get to Undo – Part 1
What if your blockbuster biologic stumbled—not because the science wasn’t there, but because no one asked if it could actually be manufactured at scale?
Why Your Dormant Omics Data Is Worth More Than the Data You’ll Generate Next – Part 2
What does it take to crack the code of protein production—and why do some proteins stubbornly refuse to cooperate, despite the best efforts of scientists and engineers?
Why Your Dormant Omics Data Is Worth More Than the Data You’ll Generate Next – Part 1
Somewhere in your lab, a hard drive is quietly storing omics data that hasn’t seen the light of day in years—genome sequences, metabolomics runs, scribbled notes in aging ELNs.
Detecting 1 in 100,000 Cells: DNA Barcoding for Smarter Clone Selection – Part 2
Cell line development in biotech is a race against time and complexity, with innovators constantly seeking solutions that provide robust and scalable data for manufacturability and regulatory demands.